Endocannabinoids can shut down virulence programs in gut bacteria
The endocannabinoid 2-AG directly inhibited bacterial virulence in mice, protecting them from gut infections caused by Enterobacteriaceae pathogens.
Quick Facts
What This Study Found
Mice with elevated 2-AG levels were protected from enteric infection. The endocannabinoid directly blocked the bacterial receptor QseC, a signaling molecule that activates pathogen attack systems.
Key Numbers
The study identified QseC, a histidine kinase encoded in the core Enterobacteriaceae genome, as the receptor through which 2-AG blocks type three secretion systems essential for infection.
How They Did This
Researchers used mouse models with elevated 2-AG levels and exposed them to Enterobacteriaceae pathogens. They identified the bacterial receptor QseC as the target through which 2-AG inhibits virulence gene expression.
Why This Research Matters
This is the first demonstration that endocannabinoids are directly sensed by bacteria and can modulate bacterial behavior, opening a new avenue for understanding how the endocannabinoid system influences gut health and infection resistance.
The Bigger Picture
The finding suggests endocannabinoids play a previously unknown role in host defense against gut infections, adding antimicrobial properties to the growing list of endocannabinoid system functions.
What This Study Doesn't Tell Us
This was an animal study using mouse models, and the relevance to human gut infections remains to be established. The study focused on Enterobacteriaceae pathogens specifically.
Questions This Raises
- ?Could cannabinoid-based therapies help prevent or treat certain bacterial gut infections?
- ?Do phytocannabinoids like THC or CBD have similar effects on bacterial virulence?
Trust & Context
- Key Stat:
- 2-AG directly inhibited bacterial virulence by blocking the QseC receptor
- Evidence Grade:
- Preliminary: animal study demonstrating a novel mechanism, not yet validated in humans.
- Study Age:
- Published in 2020 in Cell.
- Original Title:
- Endocannabinoids Inhibit the Induction of Virulence in Enteric Pathogens.
- Published In:
- Cell, 183(3), 650-665.e15 (2020)
- Authors:
- Ellermann, Melissa, Pacheco, Alline R, Jimenez, Angel G, Russell, Regan M, Cuesta, Santiago, Kumar, Aman, Zhu, Wenhan, Vale, Gonçalo, Martin, Sarah A, Raj, Prithvi, McDonald, Jeffrey G, Winter, Sebastian E, Sperandio, Vanessa
- Database ID:
- RTHC-02529
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
How did endocannabinoids protect against infection?
2-AG blocked the bacterial receptor QseC, which pathogens need to activate their attack systems. Without this signal, bacteria could not mount an effective infection.
Does this mean cannabis prevents gut infections?
Not necessarily. This study used the body's own endocannabinoid (2-AG), not plant-derived cannabinoids. Whether phytocannabinoids produce similar effects on bacteria is unknown.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-02529APA
Ellermann, Melissa; Pacheco, Alline R; Jimenez, Angel G; Russell, Regan M; Cuesta, Santiago; Kumar, Aman; Zhu, Wenhan; Vale, Gonçalo; Martin, Sarah A; Raj, Prithvi; McDonald, Jeffrey G; Winter, Sebastian E; Sperandio, Vanessa. (2020). Endocannabinoids Inhibit the Induction of Virulence in Enteric Pathogens.. Cell, 183(3), 650-665.e15. https://doi.org/10.1016/j.cell.2020.09.022
MLA
Ellermann, Melissa, et al. "Endocannabinoids Inhibit the Induction of Virulence in Enteric Pathogens.." Cell, 2020. https://doi.org/10.1016/j.cell.2020.09.022
RethinkTHC
RethinkTHC Research Database. "Endocannabinoids Inhibit the Induction of Virulence in Enter..." RTHC-02529. Retrieved from https://rethinkthc.com/research/ellermann-2020-endocannabinoids-inhibit-the-induction
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.